These benefits, along with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 aid the thought of focusing on ACKR3 as a singular way to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked Diseases. “Overall, the discovery of https://robertc159woj8.rimmablog.com/profile